Asian Ethnicity Is a Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer (NSCLC) and Is Independent of Smoking Status

被引:118
作者
Ignatius, Sai-Hong [1 ,2 ,3 ]
Ziogas, Argyrios [3 ]
Zell, Jason A. [2 ,3 ]
机构
[1] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Genet Epidemiol Res Inst, Med Ctr,Div Hematol Oncol,Dept Internal Med, Orange, CA 92868 USA
[2] Univ Irvine, Med Ctr, Dept Med, Div Hematol Oncol, Orange, CA USA
[3] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA
关键词
Never-smoker; Prognostic factors; Asian ethnicity; Hispanic ethnicity; epidemiology; Non-small cell lung cancer; California Cancer Registry; NEVER-SMOKERS; PHASE-III; EXPRESSION; ADENOCARCINOMA; CLASSIFICATION; EPIDEMIOLOGY; GEFITINIB; CARCINOMA;
D O I
10.1097/JTO.0b013e3181b27b15
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We previously showed that Asian ethnicity was an independent favorable prognostic factor in non-small cell lung cancer (NSCLC). Many Asian NSCLC patients were never-smokers, and never-smokers had improved survival than ever-smokers. We investigated whether Asian ethnicity is a favorable prognostic factor independent of smoking status. Methods: Retrospective population-based Study of NSCLC cases from the cancer surveillance programs of three Southern California counties from 1991 to 2005. Results: A total of 20,140 NSCLC patients with known smoking status were analyzed of which 9.1% were never-smokers and 6.5% were Asians. There was a threefold increase in the percentage of Asian never-smokers as compared with ever-smokers. Asians had the highest overall survival (OS) among the 4 major ethnicities (p < 0.0001) and never-smokers had improved OS over ever-smokers (p = 0.0183) by univariate analyses. By multivariate analyses, Asian ethnicity was an independent and favorable prognostic factor for OS (versus non-Asian; hazard ratio [HR] = 0.861, 95% confidence interval [CI]: 0.808-0.918, p < 0.0001), among smokers (versus non-Asian; HR = 0.867, 95% CI: 0.807-0.931, p < 0.0001), and among never-smokers (versus non-Asian; HR = 0.841, 95% Cl: 0.728-0.971, p = 0.0180). Never-smoker was a favorable prognostic factor if ethnicity was not accounted for (versus ever-smoker; HR = 0.936, 95% CI: 0.886-0.988, p = 0.0169) but was no longer an independent favorable prognostic factor (versus ever-smoker; HR = 0.953, 95% CI: 0.902-1.007,p = 0.0861) after accounting for ethnicity. Conclusions: Asian ethnicity is an independent favorable prognostic factor for OS in NSCLC regardless of smoking status.
引用
收藏
页码:1083 / 1093
页数:11
相关论文
共 31 条
[1]   Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer [J].
Bryant, Ayesha ;
Cerfolio, Robert James .
CHEST, 2007, 132 (01) :185-192
[2]   Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study [J].
Chang, Alex ;
Parikh, Purvish ;
Thongprasert, Sumitra ;
Tan, Eng Huat ;
Perng, Reury- Perng ;
Ganzon, Domingo ;
Yang, Chih-Hsin ;
Tsao, Chao-Jung ;
Watkins, Claire ;
Botwood, Nick ;
Thatcher, Nick .
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) :847-855
[3]  
Dibble R, 2005, J CLIN ONCOL, V23, p683S
[4]   EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer [J].
Dubey, Sarita ;
Stephenson, Patricia ;
Levy, Donna E. ;
Miller, Judith A. ;
Keller, Steven M. ;
Schiller, Joan H. ;
Johnson, David H. ;
Kolesar, Jill M. .
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (05) :406-412
[5]   Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers [J].
Dutu, T ;
Michiels, S ;
Fouret, P ;
Penault-Llorca, F ;
Validire, P ;
Benhamou, S ;
Taranchon, E ;
Morat, L ;
Grunenwald, D ;
Le Chevalier, T ;
Sabatier, L ;
Soria, JC .
ANNALS OF ONCOLOGY, 2005, 16 (12) :1906-1914
[6]   A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada clinical trials group study BR.21 [J].
Florescu, Marie ;
Hasan, Baktiar ;
Seymour, Lesley ;
Ding, Keyue ;
Shepherd, Frances A. .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) :590-598
[7]   Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas [J].
Fujisawa, T ;
Iizasa, T ;
Saitoh, Y ;
Sekine, Y ;
Motohashi, S ;
Yasukawa, T ;
Shibuya, K ;
Hiroshima, K ;
Ohwada, H .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2086-2091
[8]   BRONCHOGENIC CANCER IN PATIENTS UNDER 40 YEARS OLD - THE EXPERIENCE OF A LATIN-AMERICAN COUNTRY [J].
GREEN, LS ;
FORTOUL, TI ;
PONCIANO, G ;
ROBLES, C ;
RIVERO, O .
CHEST, 1993, 104 (05) :1477-1481
[9]   Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial [J].
Kim, Edward S. ;
Hirsh, Vera ;
Mok, Tony ;
Socinski, Mark A. ;
Gervais, Radj ;
Wu, Yi-Long ;
Li, Long-Yun ;
Watkins, Claire L. ;
Sellers, Mark V. ;
Lowe, Elizabeth S. ;
Sun, Yan ;
Liao, Mei-Lin ;
Osterlind, Kell ;
Reck, Martin ;
Armour, Alison A. ;
Shepherd, Frances A. ;
Lippman, Scott M. ;
Douillard, Jean-Yves .
LANCET, 2008, 372 (9652) :1809-1818
[10]  
Liu WQ, 2003, CLIN CANCER RES, V9, P1009